Survival estimates for allogeneic (Allo) and autologous (Auto) transplants comparing patients who bled (BLD) with patients who did not bleed within 100 days after transplantation (NBLD). In allogeneic patients, the median survival in 260 NBLD was greater than 33 months, compared with 3.5 months in 184 BLD (P < .0001). In autologous patients, median survival in 612 NBLD was 42.9 months, compared with 11 months in 270 BLD (P < .0001).